Posts
May 08 2022
Creative Medical Technology Holdings, Inc. announced the closing of its Private Placement offering in the amount of $17,000,000. EG&S acted as counsel to the Placement Agent.
May 02 2022
ClimateRock, a newly organized blank check company, announced the closing of its previously announced initial public offering in the amount of $75,000,000. EGS acted as counsel to ClimateRock.
May 02 2022
GeoVax Labs, Inc. announced the closing of its Registered Direct and Private Placement offering in the amount of $20,000,000. EG&S acted as counsel to the Placement Agent.
April 27 2022
Client Alert: New Notice & Posting Requirement For NY Employers That Monitor Employees’ Electronic Communications
Effective May 7, 2022, employers in New York that monitor or otherwise intercept employees’ telephone conversations, electronic mail (email), or internet access or usage by any electronic device or system, including but not limited to the use of a computer, telephone, wire, radio or electromagnetic, photoelectronic or photo-optical systems (“Electronic Monitoring”), will be subject to new notice and posting requirements.
Click here to read the alert.
April 25 2022
Clarus Therapeutics Holdings, Inc. announced the pricing of its underwritten public offering in the amount of $30,000,000. EGS acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.
April 25 2022
Aclarion, Inc. announced the pricing of its initial public offering in the amount of $9,400,000. EGS acted as counsel to Maxim Group LLC, the sole book-running manager in connection with the offering.
April 22 2022
Salarius Pharmaceuticals, Inc. announced the closing of its Registered Direct offering in the amount of $2,334,859. EG&S acted as counsel to the Placement Agent.
April 21 2022
Dermata Therapeutics announced the pricing of its private placement in the amount of $5,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.